APAX GLOBAL ALPHA LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 151 GBX | -1.18% |
|
-2.58% | -6.09% |
| May. 07 | Apax Global Fund says Apax IX to sell Healthium MedTech interest | AN |
| May. 07 | Apax Global Alpha-backed Apax IX Fund to Sell Indian Medical Device Company Healthium MedTech | MT |
Valuation
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Capitalization 1 | 1,326 | 1,045 | 910.4 | 870.8 |
| Enterprise Value (EV) 1 | 1,326 | 1,045 | 910.4 | 870.8 |
| P/E ratio | 3.85 x | - | - | - |
| Yield | - | 6.44% | - | 9.38% |
| Capitalization / Revenue | - | -10.4 x | 13 x | 4.13 x |
| EV / Revenue | - | -10.4 x | 13 x | 4.13 x |
| EV / EBITDA | - | - | - | - |
| EV / FCF | - | - | - | - |
| FCF Yield | - | - | - | - |
| Price to Book | - | - | - | - |
| Nbr of stocks (in thousands) | 491,101 | 491,101 | 491,101 | 491,101 |
| Reference price 2 | 2.701 | 2.128 | 1.854 | 1.773 |
| Announcement Date | 3/2/22 | 3/2/23 | 3/5/24 | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Net sales 1 | - | -100.1 | 69.97 | 210.9 |
| EBITDA | - | - | - | - |
| EBIT 1 | - | -106.7 | 56.7 | 200.8 |
| Operating Margin | - | 106.52% | 81.04% | 95.24% |
| Earnings before Tax (EBT) | - | - | - | - |
| Net income | 344.9 | - | - | - |
| Net margin | - | - | - | - |
| EPS | 0.7023 | - | - | - |
| Free Cash Flow | - | - | - | - |
| FCF margin | - | - | - | - |
| FCF Conversion (EBITDA) | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - |
| Dividend per Share 2 | - | 0.1370 | - | 0.1663 |
| Announcement Date | 3/2/22 | 3/2/23 | 3/5/24 | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Net Debt | - | - | - | - |
| Net Cash position | - | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | - |
| Free Cash Flow | - | - | - | - |
| ROE (net income / shareholders' equity) | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - |
| Assets | - | - | - | - |
| Book Value Per Share | - | - | - | - |
| Cash Flow per Share | - | - | - | - |
| Capex | - | - | - | - |
| Capex / Sales | - | - | - | - |
| Announcement Date | 3/2/22 | 3/2/23 | 3/5/24 | - |
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.773
EUR
Average target price
2.349
EUR
Spread / Average Target
+32.47%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -6.09% | 945M | |
| +6.59% | 13.12B | |
| +12.07% | 9.57B | |
| +0.70% | 5.63B | |
| +4.64% | 5.38B | |
| +6.91% | 5.25B | |
| +25.62% | 4.92B | |
| +20.77% | 4.61B | |
| +2.73% | 4.08B | |
| +2.80% | 3.89B |
- Stock Market
- Equities
- APAX Stock
- Financials Apax Global Alpha Limited
